Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-7772
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance ; volume:27 ; number:6 ; day:20 ; month:4 ; year:2022 ; pages:1061-1067 ; date:6.2022
International journal of clinical oncology ; 27, Heft 6 (20.4.2022), 1061-1067, 6.2022
- Creator
-
Uemura, Hirotsugu
Tomita, Yoshihiko
Nonomura, Norio
Yoshizaki, Kenji
Nakao, Takafumi
Shinohara, Nobuo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10147-022-02155-3
- URN
-
urn:nbn:de:101:1-2022072119261229826324
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Uemura, Hirotsugu
- Tomita, Yoshihiko
- Nonomura, Norio
- Yoshizaki, Kenji
- Nakao, Takafumi
- Shinohara, Nobuo
- SpringerLink (Online service)
Other Objects (12)
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
Safety and Efficacy of Melatonin in Chronic Tension-Type Headache: A Post-Marketing Real-World Surveillance Program
Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
Safety and Efficacy of Melatonin in Chronic Tension-Type Headache: A Post-Marketing Real-World Surveillance Program
Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-marketing surveillance of anti-malarial medicines used in Malawi
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
Safety and Efficacy of Melatonin in Chronic Tension-Type Headache: A Post-Marketing Real-World Surveillance Program
Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection